Behavioral sensitization following a single apomorphine pretreatment--selective effects on the dopamine release...

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• Repeated daily administration of the dopamine (DA) agonist apomorphine (APO) leads to adaptations in striatal DA synthesis and metabolism.
• These adaptations suggest that the effects of APO do not fully resolve within a 24-hour period.

Purpose of the Study:

• To investigate the behavioral and neurochemical effects of a single APO treatment administered 24 hours prior to assessment.
• To determine the impact of this pretreatment on striatal DA synthesis, metabolism, release, and receptor binding.

Main Methods:

• Rats were administered a single dose of APO.
• 24 hours later, behavioral responses to a subsequent APO challenge were evaluated.
• Striatal synaptosomes were isolated to measure DA release.
• Striatal tissue was analyzed for DA synthesis, metabolism, and D2 receptor binding.

Main Results:

• A single APO pretreatment 24 hours before testing reduced DA release from striatal synaptosomes.
• Striatal DA synthesis, metabolism, and high-affinity D2 receptor binding were not significantly altered at this time point.
• The stereotypic behavioral response to a subsequent APO challenge was enhanced.

Conclusions:

• A single APO pretreatment induces specific adaptive changes that persist for at least 24 hours.
• These adaptations differ from those observed after acute (60 min) or subchronic APO administration.
• The findings highlight the complex temporal dynamics of dopamine agonist-induced neuroadaptations.